Compare LQDA & BLDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LQDA | BLDR |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | RETAIL: Building Materials |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.7B |
| IPO Year | 2020 | 2005 |
| Metric | LQDA | BLDR |
|---|---|---|
| Price | $34.32 | $54.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 24 |
| Target Price | $54.38 | ★ $71.36 |
| AVG Volume (30 Days) | ★ 4.6M | 2.3M |
| Earning Date | 11-02-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.81 | N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | $158,320,000.00 | ★ $15,190,638,000.00 |
| Revenue This Year | $357.27 | N/A |
| Revenue Next Year | $1.34 | $2.18 |
| P/E Ratio | $27.38 | ★ N/A |
| Revenue Growth | ★ 1031.18 | N/A |
| 52 Week Low | $21.97 | $49.67 |
| 52 Week High | $93.61 | $131.50 |
| Indicator | LQDA | BLDR |
|---|---|---|
| Relative Strength Index (RSI) | 34.77 | 42.25 |
| Support Level | $32.63 | N/A |
| Resistance Level | $42.62 | $61.82 |
| Average True Range (ATR) | 2.90 | 1.89 |
| MACD | 0.11 | 0.16 |
| Stochastic Oscillator | 23.72 | 56.78 |
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.